Neuronetics Inc
STIM4.670USD
+0.250+5.66%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
307.38MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Neuronetics Inc Unternehmen
Neuronetics, Inc. is a medical technology company focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its NeuroStar Advanced Therapy for Mental Health is a non-drug, noninvasive treatment for people suffering from neurohealth conditions. In addition to selling the NeuroStar system and associated treatment sessions to customers, it operates treatment centers across the United States, offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or TMS) and Spravato (esketamine nasal spray) for the treatment of major depressive disorder (MDD) and other mental health disorders. NeuroStar Advanced Therapy is the TMS treatment for MDD in adults. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It provides more than 1.68 million treatments to over 51,000 patients struggling with depression.
Unternehmensinformationen
BörsenkürzelSTIM
Name des UnternehmensNeuronetics Inc
IPO-datumJun 28, 2018
CEOMr. Keith J. Sullivan
Anzahl der mitarbeiter716
WertpapierartOrdinary Share
GeschäftsjahresendeJun 28
Addresse3222 Phoenixville Pike
StadtMALVERN
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl19355
Telefon18776007555
Websitehttps://neurostar.com/neuronetics/
BörsenkürzelSTIM
IPO-datumJun 28, 2018
CEOMr. Keith J. Sullivan
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.02M
+1.50%
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.61M
--
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
578.24K
+6.69%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
327.90K
+10.07%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
178.03K
+20.27%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+27.05%
Mr. W. Andrew Macan
Mr. W. Andrew Macan
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
--
--
Dr. Avinash N. Amin, M.D.
Dr. Avinash N. Amin, M.D.
Director
Director
--
--
Mr. Mark Klausner
Mr. Mark Klausner
Managing Partner
Managing Partner
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.02M
+1.50%
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.61M
--
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
578.24K
+6.69%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
327.90K
+10.07%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
178.03K
+20.27%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinic revenue
18.66M
58.35%
Treatment sessions
9.76M
30.53%
NeuroStar Advanced Therapy System
3.01M
9.41%
Other
544.00K
1.70%
Nach RegionUSD
Name
Umsatz
Anteil
United States
31.48M
98.46%
International
492.00K
1.54%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinic revenue
18.66M
58.35%
Treatment sessions
9.76M
30.53%
NeuroStar Advanced Therapy System
3.01M
9.41%
Other
544.00K
1.70%
Aktionärsstatistik
Aktualisiert: Thu, Jul 17
Aktualisiert: Thu, Jul 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Madryn Asset Management, LP
36.82%
The Vanguard Group, Inc.
3.50%
Cucuz (Sasha)
3.08%
Sullivan (Keith J)
2.44%
Balyasny Asset Management LP
2.15%
Other
52.00%
Aktionäre
Aktionäre
Anteil
Madryn Asset Management, LP
36.82%
The Vanguard Group, Inc.
3.50%
Cucuz (Sasha)
3.08%
Sullivan (Keith J)
2.44%
Balyasny Asset Management LP
2.15%
Other
52.00%
Aktionärstypen
Aktionäre
Anteil
Private Equity
36.82%
Hedge Fund
12.75%
Individual Investor
9.48%
Investment Advisor
7.53%
Investment Advisor/Hedge Fund
3.50%
Research Firm
1.84%
Pension Fund
0.09%
Bank and Trust
0.03%
Other
27.96%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
183
47.01M
71.42%
-4.23M
2025Q1
191
47.19M
71.70%
-4.84M
2024Q4
155
36.70M
70.38%
+11.74M
2024Q3
153
14.58M
47.42%
-9.85M
2024Q2
159
20.22M
66.61%
-5.87M
2024Q1
183
20.38M
68.24%
-3.49M
2023Q4
191
18.37M
63.28%
-7.87M
2023Q3
201
19.69M
68.24%
-8.69M
2023Q2
222
21.10M
73.37%
-11.20M
2023Q1
226
22.33M
78.62%
-9.89M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Madryn Asset Management, LP
24.24M
36.82%
--
--
Mar 24, 2025
The Vanguard Group, Inc.
2.31M
3.5%
+1.02M
+79.97%
Mar 31, 2025
Cucuz (Sasha)
2.02M
3.08%
+30.00K
+1.50%
May 22, 2025
Sullivan (Keith J)
1.61M
2.44%
--
--
Mar 24, 2025
Balyasny Asset Management LP
1.42M
2.15%
-64.72K
-4.37%
Mar 31, 2025
Ikarian Capital LLC
1.10M
1.67%
+1.10M
--
Mar 31, 2025
Masters Capital Management, L.L.C.
1.00M
1.52%
-500.00K
-33.33%
Mar 31, 2025
Manatuck Hill Partners, LLC
920.00K
1.4%
+920.00K
--
Mar 31, 2025
Susquehanna International Group, LLP
761.91K
1.16%
+761.91K
--
Mar 31, 2025
Two Sigma Investments, LP
703.67K
1.07%
+703.67K
--
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
AdvisorShares Psychedelics ETF
6.11%
Invesco NASDAQ Future Gen 200 ETF
0.4%
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Mehr Anzeigen
AdvisorShares Psychedelics ETF
Anteil6.11%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.4%
iShares Micro-Cap ETF
Anteil0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
iShares Russell 2000 Growth ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0%
Proshares Ultra Russell 2000
Anteil0%
ProShares UltraPro Russell2000
Anteil0%
iShares Russell 2000 ETF
Anteil0%
Global X Russell 2000 ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
